Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 8, 2026
Back to directoryMedical imaging AI platform for chest X-ray and CT workflows, with FDA-cleared red dot pneumothorax triage and Behold.ai-marketed lung cancer and CT head pathway modules.
Radiology services that need a governed chest X-ray triage or high-confidence-normal workflow and can validate the exact module, indication, and radiologist review model before go-live.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Behold.ai red dot as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat each red dot module and geography separately. K191556 supports adult chest X-ray pneumothorax prioritization, not a blanket authorization for lung cancer rule-out, CT head triage, autonomous reporting, or unsupported indications. |
|---|---|
| Privacy | Review DICOM routing, image-copy handling, anonymization, identifiers, support access, audit logs, retention, international transfer, customer privacy terms, and whether the available privacy notice is only website/cookie-oriented rather than a clinical data processing agreement. |
| Evidence | Validate vendor-reported chest X-ray performance, 510(k) performance data, NHS case-study claims, local scanner and population mix, alert precision, missed-case review, normal-reporting thresholds, and radiologist workload impact. |
| Workflow | Best governed as a radiologist-supervised imaging triage service with explicit exception queues, indication-specific reporting language, downtime paths, post-deployment monitoring, and separate approval for any autonomous normal-reporting workflow. |
Behold.ai describes red dot as an AI medical imaging platform for CT and X-ray, including a lung cancer chest X-ray pathway and CT head module; FDA records list Red Dot K191556 as a radiological computer-assisted prioritization device for adult chest X-rays with features suggestive of pneumothorax, and the 510(k) summary says results are for worklist prioritization or triage, not stand-alone clinical decision-making or ruling out pneumothorax.
Not for: Replacing radiologist interpretation, assuming lung cancer or CT head claims share the same FDA clearance as K191556, ruling out pneumothorax in the United States, unsupported pediatric or non-chest workflows, or autonomous diagnosis without local authorization.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.